#lintonpharm

Collection of lintonpharm news, found 4 news.

LintonPharm to release data on Catumaxomab for advanced Gastric Cancer with peritoneal metastasis at 2022 ASCO Annual Meeting

LintonPharm to release data on Catumaxomab for advanced Gastric Cancer with peritoneal metastasis at 2022 ASCO Annual Meeting

  • 28th May 2022

LintonPharm Co., Ltd., a China-based biopharmaceutical company focusing on the development of T cell engaging ...

LintonPharm announces first patient dosed in Phase 1 clinical trial of catumaxomab for Non-Muscle-Invasive Bladder Cancer unresponsive to Bacillus Calmette-Guerin

LintonPharm announces first patient dosed in Phase 1 clinical trial of catumaxomab for Non-Muscle-Invasive Bladder Cancer unresponsive to Bacillus Calmette-Guerin

  • 2nd December 2021

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

LintonPharm announces authorization from China health authority (NMPA) to proceed with a phase 1/2 trial evaluating catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer

LintonPharm announces authorization from China health authority (NMPA) to proceed with a phase 1/2 trial evaluating catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer

  • 15th April 2021

LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell ...

LintonPharm announces authorization from China health authority to proceed with a global Phase 3 trial evaluating Catumaxomab in advanced gastric cancer

LintonPharm announces authorization from China health authority to proceed with a global Phase 3 trial evaluating Catumaxomab in advanced gastric cancer

  • 16th July 2020

- LintonPharm Co. Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T-cell ...